BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten

Cell Research

Volumn 19, Issue 2, 2009, Pages 196-207

  Cheng, Shuhua ^a,e   Hsia, Constance Yu ^a   Feng, Biao ^a   Liou, Mei Ling ^b,e   Fang, Xiaoying ^c   Pandolfi, Pier Paolo ^d   Liou, Hsiou Chi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NONE   (United States)

Author keywords

Apoptosis; B cell receptor; B cell tolerance; Pten

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ANIMAL; APOPTOSIS; ARTICLE; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; PRE B LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; MICE; MICE, KNOCKOUT; PRECURSOR CELLS, B-LYMPHOID; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTORS, ANTIGEN, B-CELL;

EID: 59449110920     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.284     Document Type: Article

References (53)

1. Healy JI, Goodnow CC. Positive versus negative signaling by lymphocyte antigen receptors. Annu Rev Immunol 1998;16:645-670.
2. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006;6:728-740.
3. Lawton AR, III, Cooper MD. Modification of B lymphocyte differentiation by anti-immunoglobulins. Contemp Top Immunobiol 1974;3:193-225.
4. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989;337:562-566.
5. Goodnow CC. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 1992;10:489-518.
6. Murakami M, Tsubata T, Okamoto M, et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992;357:77-80.
7. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005;5:189-200.
8. Eeva J, Pelkonen J. Mechanisms of B cell receptor induced apoptosis. Apoptosis 2004;9:525-531.
9. Gottlieb E, Armour SM, Harris MH, Thompson CB. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 2003;10:709-717.
10. Lakhani SA, Masud A, Kuida K, et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006;311:847-851.
11. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626-629.
12. Takada E, Hata K, Mizuguchi J. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31. Exp Cell Res 2006;312:3728-3738.
13. Shiokawa D, Shika Y, Araki S, et al. Stage-specific expression of DNasegamma during B-cell development and its role in B-cell receptor-mediated apoptosis in WEHI-231 cells. Cell Death Differ 2007;14:992-1000.
14. Avramidou A, Kroczek C, Lang C, et al. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes BCR-induced apoptosis. Cell Death Differ 2007;14:1-12.
15. Katz E, Deehan MR, Seatter S, et al. B cell receptor-stimulated mitochondrial phospholipase A2 activation and resultant disruption of mitochondrial membrane potential correlate with the induction of apoptosis in WEHI-231 B cells. J Immunol 2001;166:137-147.
16. Enders A, Bouillet P, Puthalakath H, et al. Loss of the proapoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003;198:1119-1126.
17. Takeuchi O, Fisher J, Suh H, et al. Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci USA 2005;102:11272-11277.
18. Monroe JG. B-cell antigen receptor signaling in immaturestage B cells: integrating intrinsic and extrinsic signals. Curr Top Microbiol Immunol 2000;245:1-29.
19. King LB, Norvell A, Monroe JG. Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J Immunol 1999;162:2655-2662.
20. Feng B, Cheng S, Hsia CY, et al. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol 2004;232:9-20.
21. Kovesdi D, Paszty K, Enyedi A, et al. Antigen receptor-mediated signaling pathways in transitional immature B cells. Cell Signal 2004;16:881-889.
22. Cheng S, Hsia CY, Leone G, Liou HC. Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel-/- B cells. Oncogene 2003;22:8472-8486.
23. Owyang AM, Tumang JR, Schram BR, et al. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J Immunol 2001;167:4948-4956.
24. Tumang JR, Owyang A, Andjelic S, et al. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur J Immunol 1998;28:4299-4312.
25. Grumont RJ, Rourke IJ, O'Reilly LA, et al. B lymphocytes differentially use the Rel and nuclear factor kappaBl (NFkappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 1998;187:663-674.
26. Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002;2:945-956.
27. Schulze-Luehrmann J, Ghosh S. Antigen-receptor signaling to nuclear factor kappa B. Immunity 2006;25:701-715.
28. Andjelic S, Hsia C, Suzuki H, et al. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J Immunol 2000;165:3860-3867.
29. Di Cristofano A, Kotsi P, Peng YF, et al. Impaired Fas response and autoimmunity in Pten+/- mice. Science 1999;285:2122-2125.
30. Suzuki A, Yamaguchi MT, Ohteki T, et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 2001;14:523-534.
31. Suzuki A, Kaisho T, Ohishi M, et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 2003;197:657-667.
32. Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD 19 function. Nat Immunol 2003;4:287-294.
33. Fruman DA, Snapper SB, Yballe CM, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 1999;283:393-397.
34. Suzuki H, Terauchi Y, Fujiwara M, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999;283:390-392.
35. Rickert RC, Roes J, Rajewsky K. B lymphocyte-specific, Cremediated mutagenesis in mice. Nucleic Acids Res 1997;25:2.
36. Norvell A, Monroe JG. Acquisition of surface IgD fails to protect from tolerance-induction. Both surface IgM- and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes. J Immunol 1996;156:1328-1332.
37. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003;11:577-590.
38. Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996;85:549- 561.
39. Sabapathy K, Kallunki T, David JP, et al. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 2001;193:317-328.
40. Zhu Y, Hoell P, Ahlemeyer B, Krieglstein J. PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 2006;11:197-207.
41. Feng B, Cheng S, Pear WS, Liou HC. NF-KB inhibitor blocks B cell development at two checkpoints. Med Immunol 2004;3:1.
42. Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell 2001;8:317-325.
43. Allman D, Lindsley RC, DeMuth W, et al. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001;167:6834-6840.
44. Trotman LC, Niki M, Dotan ZA, et al. Pten dose dictates cancer progression in the prostate. PLoSBiol 2003;1:E59.
45. Liou HC, Hsia CY. Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease. Bioessays 2003;25:767-780.
46. Grossmann M, Nakamura Y, Grumont R, Gerondakis S. New insights into the roles of ReL/NF-kappa B transcription factors in immune function, hemopoiesis and human disease. Int J Biochem Cell Biol 1999;31:1209-1219.
47. Grumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of Al transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999;13:400-411.
48. Koncz G, Bodor C, Kovesdi D, Gati R, Sarmay G. BCR mediated signal transduction in immature and mature B cells. Immunol Lett 2002;82:41-49.
49. Deane JA, Fruman DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004;22:563-598.
50. Greer E, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005;24:7410-7425.
51. Pillai S, Cariappa A, Moran ST. Marginal zone B cells. Annu Rev Immunol 2005;23:161-196.
52. Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 2002;14:905-916.
53. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1994;91:10148-10152.